Posted inTechnology News
Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch – DBV Technologies (NASDAQ:DBVT)
DBV Technologies DBVT DBVTF announced that its Phase 3 EPITOPE trial of epicutaneous immunotherapy (EPIT) with Viaskin Peanut in children 1 – 3 years was published in the New England…